Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Joffre Baker, Steven Shak, Felix Baker

Premium

Joffre Baker is no longer chief scientific officer at Genomic Health, the company disclosed this week in a filing with the US Securities and Exchange Commission. Baker is now a senior fellow at the company. Steven Shak, chief medical officer, has assumed responsibility for managing the research operations, which were formerly handled by Baker.

Additionally, Genomic Health's board of directors appointed Felix Baker as a member of the board and to the board's compensation committee. He is currently director of Seattle Genetics and Synageva BioPharm. He holds a BS and PhD in immunology from Stanford University.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.